1
|
D'Agostino I, Zara S, Carradori S, De Luca V, Capasso C, Kocken CHM, Zeeman AM, Angeli A, Carta F, Supuran CT. Antimalarial Agents Targeting Plasmodium falciparum Carbonic Anhydrase: Towards Artesunate Hybrid Compounds with Dual Mechanism of Action. ChemMedChem 2023; 18:e202300267. [PMID: 37697903 DOI: 10.1002/cmdc.202300267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Revised: 09/07/2023] [Accepted: 09/07/2023] [Indexed: 09/13/2023]
Abstract
Malaria continues to be a major public health challenge worldwide and, as part of the global effort toward malaria eradication, plasmodium carbonic anhydrases (CAs) have recently been proposed as potential targets for malaria treatment. In this study, a series of eight hybrid compounds combining the Artesunate core with a sulfonamide moiety were synthesized and evaluated for their inhibition potency against the widely expressed human (h) CAs I, II and the isoform from P. falciparum (PfCA). All derivatives demonstrated high inhibition potency against PfCA, achieving a KI value in the sub-nanomolar range (0.35 nM). Two Compounds showed a selectivity index of 4.1 and 3.1, respectively, against this protozoan isoform compared to hCA II. Three Derivatives showed no cytotoxic effects on human gingival fibroblasts at 50 μM with a high killing rate against both P. falciparum and P. knowlesi strains with IC50 in the sub-nanomolar range, providing a wide therapeutic window. Our findings suggest that these compounds may serve as promising leads for developing new antimalarial drugs and warrant further investigation, including activity against antimalarial-resistant strains, mode of action studies, and in vivo efficacy assessment in preclinical mouse models of malaria.
Collapse
Affiliation(s)
- Ilaria D'Agostino
- Department of Pharmacy "G. d'Annunzio", University of Chieti-Pescara, 66100, Chieti, Italy
| | - Susi Zara
- Department of Pharmacy "G. d'Annunzio", University of Chieti-Pescara, 66100, Chieti, Italy
| | - Simone Carradori
- Department of Pharmacy "G. d'Annunzio", University of Chieti-Pescara, 66100, Chieti, Italy
| | - Viviana De Luca
- Istituto di Bioscienze e Biorisorse CNR, 80131, Napoli, Italy
| | | | - Clemens H M Kocken
- Department of Parasitology, Biomedical Primate Research Center, 2288, Rijswijk, The Netherlands
| | - Anne-Marie Zeeman
- Department of Parasitology, Biomedical Primate Research Center, 2288, Rijswijk, The Netherlands
| | - Andrea Angeli
- Neurofarba Department, University of Florence, 50019, Sesto Fiorentino FL, Italy
| | - Fabrizio Carta
- Neurofarba Department, University of Florence, 50019, Sesto Fiorentino FL, Italy
| | - Claudiu T Supuran
- Neurofarba Department, University of Florence, 50019, Sesto Fiorentino FL, Italy
| |
Collapse
|
2
|
Alissa SA, Alghulikah HA, ALOthman ZA, Osman SM, Del Prete S, Capasso C, Nocentini A, Supuran CT. Inhibition survey with phenolic compounds against the δ- and η-class carbonic anhydrases from the marine diatom thalassiosira weissflogii and protozoan Plasmodium falciparum. J Enzyme Inhib Med Chem 2019; 35:377-382. [PMID: 31856608 PMCID: PMC6968676 DOI: 10.1080/14756366.2019.1706089] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
The inhibition of δ- and η-class carbonic anhydrases (CAs; EC 4.2.1.1) was poorly investigated so far. Only one δ-CA, TweCA from the diatom Thalassiosira weissflogii, and one η-CA, PfCA, from Plasmodium falciparum, have been cloned and characterised to date. To enrich δ- and η-CAs inhibition profiles, a panel of 22 phenols was investigated for TweCA and PfCA inhibition. Some derivatives showed effective, sub-micromolar inhibition of TweCA (KIs 0.81–65.4 µM) and PfCA (KIs 0.62–78.7 µM). A subset of compounds demonstrated a significant selectivity for the target CAs over the human physiologically relevant ones. This study promotes the identification of new potent and selective inhibitors of TweCA and PfCA, which could be considered as leads for finding molecular probes in the study of carbon fixation processes (in which TweCA and orthologue enzymes are involved) or drug candidates in the treatment of malaria.
Collapse
Affiliation(s)
- Siham A Alissa
- Chemistry Department, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
| | - Hanan A Alghulikah
- Chemistry Department, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
| | - Zeid A ALOthman
- Chemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia
| | - Sameh M Osman
- Chemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia
| | | | | | - Alessio Nocentini
- NEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Sesto Fiorentino, Firenze, Italy
| | - Claudiu T Supuran
- NEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Sesto Fiorentino, Firenze, Italy
| |
Collapse
|
5
|
Fisher GM, Bua S, Del Prete S, Arnold MSJ, Capasso C, Supuran CT, Andrews KT, Poulsen SA. Investigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria data. INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE 2017; 7:61-70. [PMID: 28129569 PMCID: PMC5271676 DOI: 10.1016/j.ijpddr.2017.01.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/30/2016] [Revised: 01/11/2017] [Accepted: 01/12/2017] [Indexed: 11/17/2022]
Abstract
In the past decade there has been a significant reduction in deaths due to malaria, in part due to the success of the gold standard antimalarial treatment - artemisinin combination therapies (ACTs). However the potential threat of ACT failure and the lack of a broadly effective malaria vaccine are driving efforts to discover new chemical entities (NCEs) to target this disease. The primary sulfonamide (PS) moiety is a component of several clinical drugs, including those for treatment of kidney disease, glaucoma and epilepsy, however this chemotype has not yet been exploited for malaria. In this study 31 PS compounds sourced from the GlaxoSmithKline (GSK) Tres Cantos antimalarial set (TCAMS) were investigated for their ability to selectively inhibit the in vitro growth of Plasmodium falciparum asexual stage malaria parasites. Of these, 14 compounds were found to have submicromolar activity (IC50 0.16–0.89 μM) and a modest selectivity index (SI) for the parasite versus human cells (SI > 12 to >43). As the PS moiety is known to inhibit carbonic anhydrase (CA) enzymes from many organisms, the PS compounds were assessed for recombinant P. falciparum CA (PfCA) mediated inhibition of CO2 hydration. The PfCA inhibition activity did not correlate with antiplasmodial potency. Furthermore, no significant difference in IC50 was observed for P. falciparum versus P. knowlesi (P > 0.05), a Plasmodium species that is not known to contain an annotated PfCA gene. Together these data suggest that the asexual intraerythrocytic stage antiplasmodial activity of the PS compounds examined in this study is likely unrelated to PfCA inhibition. Mining of GSK open source antimalarial data against the primary sulfonamide chemotype was performed. The antiplasmodial activity of 31 primary sulfonamide compounds was determined. Three novel compounds displayed promising activity in two Plasmodium species. P. falciparum carbonic anhydrase was investigated as a potential target in mode of action studies.
Collapse
Affiliation(s)
- Gillian M Fisher
- Griffith Institute for Drug Discovery, Griffith University, Queensland, Australia
| | - Silvia Bua
- Neurofarba Department, Sezione di Scienze Farmaceutiche Nutraceutiche, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Sesto Fiorentino, Florence, Italy
| | - Sonia Del Prete
- Neurofarba Department, Sezione di Scienze Farmaceutiche Nutraceutiche, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Sesto Fiorentino, Florence, Italy; Istituto di Bioscienze e Biorisorse, CNR, Via Pietro Castellino 111, Napoli, Italy
| | - Megan S J Arnold
- Griffith Institute for Drug Discovery, Griffith University, Queensland, Australia
| | - Clemente Capasso
- Istituto di Bioscienze e Biorisorse, CNR, Via Pietro Castellino 111, Napoli, Italy
| | - Claudiu T Supuran
- Neurofarba Department, Sezione di Scienze Farmaceutiche Nutraceutiche, and Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Sesto Fiorentino, Florence, Italy
| | - Katherine T Andrews
- Griffith Institute for Drug Discovery, Griffith University, Queensland, Australia.
| | - Sally-Ann Poulsen
- Griffith Institute for Drug Discovery, Griffith University, Queensland, Australia.
| |
Collapse
|
11
|
Barrese, AA, Genis C, Fisher SZ, Orwenyo JN, Kumara MT, Dutta SK, Phillips E, Kiddle JJ, Tu C, Silverman DN, Govindasamy L, Agbandje-McKenna M, McKenna R, Tripp BC. Inhibition of Carbonic Anhydrase II by Thioxolone: A Mechanistic and Structural Study. Biochemistry 2008; 47:3174-84. [DOI: 10.1021/bi702385k] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Albert A. Barrese,
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| | - Caroli Genis
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| | - S. Zoe Fisher
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| | - Jared N. Orwenyo
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| | - Mudalige Thilak Kumara
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| | - Subodh K. Dutta
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| | - Eric Phillips
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| | - James J. Kiddle
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| | - Chingkuang Tu
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| | - David N. Silverman
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| | - Lakshmanan Govindasamy
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| | - Mavis Agbandje-McKenna
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| | - Robert McKenna
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| | - Brian C. Tripp
- Department of Biological Sciences, Mailstop 5410, College of Arts and Sciences, 1903 West Michigan Avenue, Western Michigan University, Kalamazoo, Michigan 49008-5410, Department of Biochemistry and Molecular Biology, College of Medicine, P.O. Box 100245, University of Florida, Gainesville, Florida 32610-0267, Department of Chemistry, Western Michigan University, Kalamazoo, Michigan 49008-5410, and Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville,
| |
Collapse
|